HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-emetic activity of the novel nonpeptide tachykinin NK1 receptor antagonist ezlopitant (CJ-11,974) against acute and delayed cisplatin-induced emesis in the ferret.

Abstract
The anti-emetic effects of a novel tachykinin NK(1) receptor antagonist, ezlopitant ((2S,3S-cis)-2-diphenylmethyl)- N-[(2-methoxy, 5-isopropylphenyl)methyl]-1-azabicyclo- [2.2.2]octan-3-amine), were investigated in ferrets. Ezlopitant inhibited [(3)H]substance P ([(3)H]SP) binding to the human, guinea pig, ferret and gerbil NK(1) receptors (K(i) = 0.2, 0.9. 0.6 and 0.5 nmol/l, respectively), but had no affinity to NK(2) and NK(3) receptors up to 1 micromol/l. Ezlopitant also inhibited SP-induced contraction of guinea pig trachea with a pA(2) value of 7.8, but had no effects on the baseline tension and maximum contractile response. In ferrets, ezlopitant, either orally (0.03-3 mg/kg) or subcutaneously (0.3-3 mg/kg), prevented acute retching and vomiting responses induced by intraperitoneal injection of cisplatin (10 mg/kg). In addition, repeated subcutaneous injection of ezlopitant significantly inhibited delayed retching and vomiting responses that occurred in ferrets treated with the lower dose of cisplatin (5 mg/kg, i.p.). Ezlopitant (0.1-1 mg/kg, s.c.) also produced a dose-dependent inhibition of hindpaw tapping induced by intracerebroventricular injection of [Sar(9),Met(O(2))(11)]SP in gerbils, which is known to be mediated by NK(1) receptors in the brain. These findings indicate that ezlopitant is a potent and selective NK(1) receptor antagonist, and that it inhibits both acute and delayed emetic reactions induced by cisplatin in ferrets via acting on NK(1) receptors in the central nervous system.
AuthorsMegumi Tsuchiya, Yoshiko Fujiwara, Yoshihito Kanai, Mayumi Mizutani, Kaoru Shimada, Osamu Suga, Satoko Ueda, John W Watson, Atsushi Nagahisa
JournalPharmacology (Pharmacology) Vol. 66 Issue 3 Pg. 144-52 (Nov 2002) ISSN: 0031-7012 [Print] Switzerland
PMID12372904 (Publication Type: Journal Article)
CopyrightCopyright 2002 S. Karger AG, Basel
Chemical References
  • Antiemetics
  • Benzylamines
  • Bridged Bicyclo Compounds, Heterocyclic
  • Neurokinin-1 Receptor Antagonists
  • Receptors, Neurokinin-1
  • ezlopitant
  • Cisplatin
Topics
  • Animals
  • Antiemetics (chemistry, pharmacology, therapeutic use)
  • Benzylamines (chemistry, pharmacology, therapeutic use)
  • Bridged Bicyclo Compounds, Heterocyclic (chemistry, pharmacology, therapeutic use)
  • Cisplatin (toxicity)
  • Cricetinae
  • Dose-Response Relationship, Drug
  • Female
  • Ferrets
  • Gerbillinae
  • Guinea Pigs
  • Humans
  • In Vitro Techniques
  • Male
  • Neurokinin-1 Receptor Antagonists
  • Protein Binding (physiology)
  • Receptors, Neurokinin-1 (physiology)
  • Vomiting (chemically induced, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: